HomeMDMA • CNSX
add
Pharmala Biotech Holdings Inc
Previous close
$0.095
Day range
$0.090 - $0.10
Year range
$0.065 - $0.34
Market cap
9.82M CAD
Avg Volume
165.12K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Feb 2025info | Y/Y change |
---|---|---|
Revenue | 145.66K | 161.97% |
Operating expense | 914.04K | 256.05% |
Net income | -810.77K | -264.28% |
Net profit margin | -556.63 | -39.05% |
Earnings per share | — | — |
EBITDA | -764.82K | -312.65% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Feb 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.51M | 3,642.00% |
Total assets | 3.91M | 57.43% |
Total liabilities | 812.25K | -28.64% |
Total equity | 3.09M | — |
Shares outstanding | 105.18M | — |
Price to book | 3.17 | — |
Return on assets | -59.52% | — |
Return on capital | -77.83% | — |
Cash Flow
Net change in cash
(CAD) | Feb 2025info | Y/Y change |
---|---|---|
Net income | -810.77K | -264.28% |
Cash from operations | -252.83K | -137.17% |
Cash from investing | -1.24M | -1,534.67% |
Cash from financing | 1.56M | — |
Net change in cash | 66.85K | 136.63% |
Free cash flow | 75.50K | 188.17% |
About
Founded
2020
Headquarters
Website